Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Sex differences in motivational responses to dietary fat in Syrian hamsters.

Shannonhouse JL, Grater DM, York D, Wellman PJ, Morgan C.

Physiol Behav. 2015 Aug 1;147:102-16. doi: 10.1016/j.physbeh.2015.04.029. Epub 2015 Apr 18.

2.

Anxiety comorbidity in bipolar spectrum disorders: the mediational role of perfectionism in prospective depressive symptoms.

O'Garro-Moore JK, Adams AM, Abramson LY, Alloy LB.

J Affect Disord. 2015 Mar 15;174:180-7. doi: 10.1016/j.jad.2014.11.024. Epub 2014 Nov 21.

3.

Coexisting anxiety and depressive symptoms in patients with heart failure.

Dekker RL, Lennie TA, Doering LV, Chung ML, Wu JR, Moser DK.

Eur J Cardiovasc Nurs. 2014 Apr;13(2):168-76. doi: 10.1177/1474515113519520. Epub 2014 Jan 9.

4.

High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illness.

Lewis AS, Picciotto MR.

Psychopharmacology (Berl). 2013 Oct;229(3):477-85. doi: 10.1007/s00213-013-3126-5. Epub 2013 Apr 28. Review.

5.

Defining anxious depression: a review of the literature.

Ionescu DF, Niciu MJ, Henter ID, Zarate CA.

CNS Spectr. 2013 Oct;18(5):252-60. doi: 10.1017/S1092852913000114. Epub 2013 Mar 14. Review.

6.

Emergence of anxiety-like behaviours in depressive-like Cpe(fat/fat) mice.

Rodriguiz RM, Wilkins JJ, Creson TK, Biswas R, Berezniuk I, Fricker AD, Fricker LD, Wetsel WC.

Int J Neuropsychopharmacol. 2013 Aug;16(7):1623-34. doi: 10.1017/S1461145713000059. Epub 2013 Feb 27.

8.

Psychosocial features associated with lifetime comorbidity of major depression and anxiety disorders among a community sample of mid-life women: the SWAN mental health study.

Cyranowski JM, Schott LL, Kravitz HM, Brown C, Thurston RC, Joffe H, Matthews KA, Bromberger JT.

Depress Anxiety. 2012 Dec;29(12):1050-7. doi: 10.1002/da.21990. Epub 2012 Aug 28.

9.

Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder.

Saricicek A, Esterlis I, Maloney KH, Mineur YS, Ruf BM, Muralidharan A, Chen JI, Cosgrove KP, Kerestes R, Ghose S, Tamminga CA, Pittman B, Bois F, Tamagnan G, Seibyl J, Picciotto MR, Staley JK, Bhagwagar Z.

Am J Psychiatry. 2012 Aug;169(8):851-9. doi: 10.1176/appi.ajp.2012.11101546.

10.

Genome-wide approaches to antidepressant treatment: working towards understanding and predicting response.

Hodgson K, Mufti SJ, Uher R, McGuffin P.

Genome Med. 2012 Jun 27;4(6):52. doi: 10.1186/gm351.

11.

New roles of carboxypeptidase E in endocrine and neural function and cancer.

Cawley NX, Wetsel WC, Murthy SR, Park JJ, Pacak K, Loh YP.

Endocr Rev. 2012 Apr;33(2):216-53. doi: 10.1210/er.2011-1039. Epub 2012 Mar 7. Review.

12.

Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder.

Goes FS, McCusker MG, Bienvenu OJ, Mackinnon DF, Mondimore FM, Schweizer B; National Institute of Mental Health Genetics Initiative Bipolar Disorder Consortium., Depaulo JR, Potash JB.

Psychol Med. 2012 Jul;42(7):1449-59. doi: 10.1017/S0033291711002637. Epub 2011 Nov 21.

13.

Depression, anxiety, and COPD: the unexamined role of nicotine dependence.

Goodwin RD, Lavoie KL, Lemeshow AR, Jenkins E, Brown ES, Fedoronko DA.

Nicotine Tob Res. 2012 Feb;14(2):176-83. doi: 10.1093/ntr/ntr165. Epub 2011 Oct 24.

14.

Cardiac vagal control in nonmedicated depressed women and nondepressed controls: impact of depression status, lifetime trauma history, and respiratory factors.

Cyranowski JM, Hofkens TL, Swartz HA, Salomon K, Gianaros PJ.

Psychosom Med. 2011 May;73(4):336-43. doi: 10.1097/PSY.0b013e318213925d. Epub 2011 Mar 1.

15.

Efficacy and tolerability of duloxetine treatment in elderly patients with major depressive disorder and concurrent anxiety symptoms.

Russell J, Raskin J, Wiltse C, Walker D, Brawman-Mintzer O.

Psychiatry (Edgmont). 2007 Jun;4(6):33-45.

16.

The relative roles of bipolar disorder and psychomotor agitation in substance dependence.

Leventhal AM, Zimmerman M.

Psychol Addict Behav. 2010 Jun;24(2):360-5. doi: 10.1037/a0019217.

17.

Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity.

Taylor TN, Caudle WM, Shepherd KR, Noorian A, Jackson CR, Iuvone PM, Weinshenker D, Greene JG, Miller GW.

J Neurosci. 2009 Jun 24;29(25):8103-13. doi: 10.1523/JNEUROSCI.1495-09.2009.

18.

Comorbid anxiety as a suicide risk factor among depressed veterans.

Pfeiffer PN, Ganoczy D, Ilgen M, Zivin K, Valenstein M.

Depress Anxiety. 2009;26(8):752-7. doi: 10.1002/da.20583.

19.
20.

Anxiety-like behaviors in mice lacking GIT2.

Schmalzigaug R, Rodriguiz RM, Phillips LE, Davidson CE, Wetsel WC, Premont RT.

Neurosci Lett. 2009 Feb 20;451(2):156-61. doi: 10.1016/j.neulet.2008.12.034. Epub 2008 Dec 24.

Supplemental Content

Support Center